These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 21224347)

  • 21. Cross-talk between Rac1 GTPase and dysregulated Wnt signaling pathway leads to cellular redistribution of beta-catenin and TCF/LEF-mediated transcriptional activation.
    Esufali S; Bapat B
    Oncogene; 2004 Oct; 23(50):8260-71. PubMed ID: 15377999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Geldanamycin destabilizes HER2 tyrosine kinase and suppresses Wnt/beta-catenin signaling in HER2 overexpressing human breast cancer cells.
    Wang K; Ma Q; Ren Y; He J; Zhang Y; Zhang Y; Chen W
    Oncol Rep; 2007 Jan; 17(1):89-96. PubMed ID: 17143483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines.
    Matsuzaki E; Takahashi-Yanaga F; Miwa Y; Hirata M; Watanabe Y; Sato N; Morimoto S; Hirofuji T; Maeda K; Sasaguri T
    J Bone Miner Res; 2006 Aug; 21(8):1307-16. PubMed ID: 16869729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wnt/beta-catenin is essential for intestinal homeostasis and maintenance of intestinal stem cells.
    Fevr T; Robine S; Louvard D; Huelsken J
    Mol Cell Biol; 2007 Nov; 27(21):7551-9. PubMed ID: 17785439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of the Wnt/beta-catenin network in regulating hematopoiesis.
    Wilusz M; Majka M
    Arch Immunol Ther Exp (Warsz); 2008; 56(4):257-66. PubMed ID: 18726147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The role of phospholipase D in cellular signaling].
    Zhong XL; Cui DC; Li YZ
    Zhi Wu Sheng Li Yu Fen Zi Sheng Wu Xue Xue Bao; 2005 Oct; 31(5):451-60. PubMed ID: 16222086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phospholipase D in cell proliferation and cancer.
    Foster DA; Xu L
    Mol Cancer Res; 2003 Sep; 1(11):789-800. PubMed ID: 14517341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Understanding of the roles of phospholipase D and phosphatidic acid through their binding partners.
    Jang JH; Lee CS; Hwang D; Ryu SH
    Prog Lipid Res; 2012 Apr; 51(2):71-81. PubMed ID: 22212660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting the Wnt/β-catenin signaling pathway in human cancers.
    Yao H; Ashihara E; Maekawa T
    Expert Opin Ther Targets; 2011 Jul; 15(7):873-87. PubMed ID: 21486121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Wnt/β-catenin pathway in ovarian cancer: a review.
    Arend RC; Londoño-Joshi AI; Straughn JM; Buchsbaum DJ
    Gynecol Oncol; 2013 Dec; 131(3):772-9. PubMed ID: 24125749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of cytoskeletal dynamics by phospholipase D and phosphatidic acid.
    Pleskot R; Li J; Zárský V; Potocký M; Staiger CJ
    Trends Plant Sci; 2013 Sep; 18(9):496-504. PubMed ID: 23664415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new link between diabetes and cancer: enhanced WNT/β-catenin signaling by high glucose.
    García-Jiménez C; García-Martínez JM; Chocarro-Calvo A; De la Vieja A
    J Mol Endocrinol; 2014 Feb; 52(1):R51-66. PubMed ID: 24049067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flavonoids: potential Wnt/beta-catenin signaling modulators in cancer.
    Amado NG; Fonseca BF; Cerqueira DM; Neto VM; Abreu JG
    Life Sci; 2011 Oct; 89(15-16):545-54. PubMed ID: 21635906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. On target? Strategies and progress in the development of therapies for colorectal cancer targeted against WNT signalling.
    McDonald SL; Silver AR
    Colorectal Dis; 2011 Apr; 13(4):360-9. PubMed ID: 20015264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenetic disruption of the WNT/beta-catenin signaling pathway in human cancers.
    Ying Y; Tao Q
    Epigenetics; 2009 Jul; 4(5):307-12. PubMed ID: 19633433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reciprocal regulation of AMP-activated protein kinase and phospholipase D.
    Mukhopadhyay S; Saqcena M; Chatterjee A; Garcia A; Frias MA; Foster DA
    J Biol Chem; 2015 Mar; 290(11):6986-93. PubMed ID: 25632961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncogenic Wnt/β-catenin signalling pathways in the cancer-resistant epididymis have implications for cancer research.
    Wang K; Li N; Yeung CH; Li JY; Wang HY; Cooper TG
    Mol Hum Reprod; 2013 Feb; 19(2):57-71. PubMed ID: 23155044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphatidic acid, phospholipase D and tumorigenesis.
    Gomez-Cambronero J
    Adv Biol Regul; 2014 Jan; 54():197-206. PubMed ID: 24103483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. mTOR signaling: PLD takes center stage.
    Sun Y; Chen J
    Cell Cycle; 2008 Oct; 7(20):3118-23. PubMed ID: 18927511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PLD1 is a key player in cancer stemness and chemoresistance: Therapeutic targeting of cross-talk between the PI3K/Akt and Wnt/β-catenin pathways.
    Lim SH; Lee H; Lee HJ; Kim K; Choi J; Han JM; Min DS
    Exp Mol Med; 2024 Jul; 56(7):1479-1487. PubMed ID: 38945955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.